Resumo
The specificity of invariant Natural Killer T (iNKT) cells for lipid antigens expressed on the CD1d molecule and their antitumoral activity in response to its exogenous agonist, ±-galactosylceramide (±GC), make them an alternative for managing cancers resistant to conventional therapies. However, despite the positive results observed in clinical trials, the antitumor efficiency of ±GC rem…